STEPHANIE URELL: Open Payments
NPI 1942642152 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,554 in 76 payments from 15 companies in 2025. Trend: 2023 $2,608 · 2024 $2,353 · 2025 $1,554
Food & beverage: $1,464Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $708 |
| Astellas Pharma US Inc | 2 | $186 |
| Novo Nordisk Inc | 5 | $118 |
| Lundbeck LLC | 4 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $92 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $29 |
Products named: QULIPTA, UBRELVY, VRAYLAR, Veozah, CAPLYTA, REXULTI, GEMTESA, VYEPTI.
Industry payments across TN — which companies pay providers there.
